For the first nine months, sales were $133.9 billion, up 7.5% year-over-year.
Latest In Pharmaceutical & Health Care
Profit for the quarter was $477 million compared to a loss of $80 million in 2019.
The company reported a loss for the quarter of $14.1 million.
The acquisition would expand the lab-equipment companys presence in the field of gene therapy.
Healthcare distributor appoints Edward A. Pesicka to top post, effective March 4.
Fiscal second-quarter increase led by growth in the companys pharmaceuticals segment.
Distributor reports solid sales growth in the U.S., double-digit increase in medical-surgical solutions business.
Company hires Brian Rice as executive vice president, chief information officer and customer support services.
Distributor will move its headquarters from San Francisco to Las Colinas, Texas, effective April 1.
Fiscal first-quarter sales reach $35.2 billion, driven by growth in both pharmaceutical and medical segments.
Victor Crawford named CEO of distributors pharmaceutical segment, effective November 12.
Company reports 7 percent sales increase in fiscal Q4, 5 percent increase for fiscal year 2018.
Acquisition drives growth in Medical segment in fiscal third quarter.
Shana Neal appointed senior vice president and chief human resources officer, effective immediately.
Pharmaceutical segment sales increased 5 percent year-over-year.
The sale includes the company's pharmaceutical and medical products distribution business in China.
